Announcements Trials
Browse Landscape Eligibility

Clinical Trials

4 trials
RecentStart dateEnrollment
Exome × Clear all

Phase

Phase NA 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Sebaceous Cell Tumor of Eyelid 1Neuroma, Acoustic 1Neurofibromatosis 2 1Lung Squamous Cell Carcinoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2681Cisplatin 2665Carboplatin 2462Radiotherapy 2370Paclitaxel 2264Gemcitabine 2128pembrolizumab 1993Docetaxel 1883Bevacizumab 1821Fluorouracil 1548Capecitabine 1532Oxaliplatin 1440Dexamethasone 1330Nivolumab 1300Doxorubicin 1260Rituximab 1249Magnetic Resonance Spectroscopy 1150Etoposide 1126Irinotecan 1038Leucovorin 1020Drug Therapy 999Cytarabine 964Pemetrexed 891fludarabine 889Specimen Handling 822Vincristine 793Lenalidomide 791Cetuximab 785Prednisone 785Trastuzumab 785

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT06080009 2024-02-23

Analysis of Molecular Biomarkers in Periocular Adnexal Tumours

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Unknown
20 enrolled

Sebaceous Cell Tumor of Eyelid

NCT05807516 2023-04-25

SCRBC

Regina Elena Cancer Institute

Unknown
20 enrolled
Breast

Breast Neoplasms

NCT05778253 2023-03-21

The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC

Second Xiangya Hospital of Central South University

Recruiting
50 enrolled

Lung Squamous Cell Carcinoma

NCT03210285 2018-07-23

NF2

University Hospital Tuebingen

Completed
70 enrolled
CNS

Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡